Home › Funds › BONNESS ENTERPRISES INC › GSK
BONNESS ENTERPRISES INC position in GSK
GSK PLC ADR F · Health Care
BONNESS ENTERPRISES INC reported holding 41,480 shares of GSK (GSK PLC ADR F) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.65% of its reported portfolio and ranking #32 among its reported holdings. BONNESS ENTERPRISES INC has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How BONNESS ENTERPRISES INC's GSK position evolved
BONNESS ENTERPRISES INC first disclosed a stake in GSK in Q3 2023 at 52,960 shares (US$1.9M). The position peaked in Q1 2026 at 41,480 shares, worth US$2.3M. Across 13 filings, BONNESS ENTERPRISES INC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 41,480 shares valued at US$2.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 52.96K | $1.92M | New |
| Q4 2023 | 52.96K | $1.96M | Hold |
| Q1 2024 | 52.96K | $2.27M | Hold |
| Q2 2024 | 52.96K | $2.04M | Hold |
| Q3 2024 | 52.96K | $2.17M | Hold |
| Q4 2024 | 41.48K | $1.40M | Reduce |
| Q1 2025 | 41.48K | $1.61M | Hold |
| Q2 2025 | 41.48K | $1.59M | Hold |
| Q3 2025 | 41.48K | $1.79M | Hold |
| Q4 2025 | 41.48K | $2.03M | Hold |
| Q1 2026 | 41.48K | $2.29M | Hold |
| Q2 2026 | 41.48K | $2.17M | Hold |
| Q3 2026 | 41.48K | $2.00M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC ADR F) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.18M sh · $1.32B · Q2 2026
- JTC Employer Solutions Trustee Ltd 8.59M sh · $450.31M · Q2 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.60M sh · $188.69M · Q2 2026
- EQUITY INVESTMENT CORP 3.27M sh · $171.40M · Q2 2026
More on BONNESS ENTERPRISES INC
FAQ
How long has BONNESS ENTERPRISES INC held GSK?
BONNESS ENTERPRISES INC has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is BONNESS ENTERPRISES INC's current position in GSK?
As of Q3 2026, BONNESS ENTERPRISES INC holds 41.48K shares of GSK (GSK PLC ADR F), valued at $2.00M, representing 0.65% of its reported portfolio and ranking #32.
Has BONNESS ENTERPRISES INC been buying or selling GSK?
In the latest 13F filing (Q3 2026), BONNESS ENTERPRISES INC held unchanged its position in GSK. The position peaked in Q1 2026 at 41.48K shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.